Sabra Health Care REIT, Inc. · REIT (real estate trust)

SBRA

Low riskNext report: In 7 days (est.)

View price ↗

The short version

A profitable company with growing sales.

Going well

Sales up 25% in the latest quarter vs a year ago
Pays a 6.1% dividend yield
Profitable, keeps 20% of sales as profit

Money moves

No insider buying or selling in the last 30 days
Institutions added 1.7% to their holdings in the quarter ending June 2026 (222 bought, 193 sold)

Facts from SEC filings, not a recommendation.

What the price means

Price as of Oct 26

$19.77+1.1% that day

Company value: $5.1B; Share price times all shares
Price vs profit (P/E): 76.0x; You pay about $76 for each $1 of yearly profit
Price vs sales: 5.9x; Company value is 5.9 times a year of sales
Dividend yield: 6.1%; Yearly dividend as a share of today's price
Cash vs value: 5%; Cash as a share of company value
Debt vs value: 50%; Debt as a share of company value

From SBRA's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.

The business over time

Last 12 quarters, from SEC filings

Sales, Jun '26

$235.9M+25% vs a year earlier

Sep '23Tap a barJun '26

Last 12 months: $859.6M, up 17% from the 12 months before. Over 5 years, sales grew about 5.3% a year.

What the price assumes

Your guesses, our math

Move the sliders to your own view of SBRA. Starting points are the company's recent numbers.

Sales growth+17% a yearRecently: +17% a yearProfit margin8%Last 12 months: 7.6%P/E at the end40xToday: 76.0x. Many steady companies trade at 12x to 25xShare count change+2% a yearBelow zero means buybacks; above zero means new shares (dilution)

Sales in 5 years$1.9B

Profit in 5 years$151M

Price these guesses point to$21.38+8.1% vs $19.77 todayAbout +1.6% a year, before dividends

What today's price needs: with a 8% margin and a 40x P/E, sales would have to grow about 15% a year for 5 years just to match today's price.

Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.

Price

Price chart by TradingView.

Business quality

The checklist Warren Buffett-style investors use. Annual numbers for 2025.

2/6Weak

MissReturn on equity 15%+Earns a lot on the money owners have in the business.5.6%
MissDebt under half of equityNot relying on borrowed money.0.90x equity
PassNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.20.1%
MissProfitable every yearSteady profits, not one good year.8 of 10 years
PassFree cash flow positiveBrings in more cash than it spends to run and grow.$348.6M
MissShare count not growingNot diluting owners. Falling means buybacks.+5.9% in 3 years

Revenue: $774.6M; +10.2% vs prior year
5-year growth: +5.3%/yr; revenue, per year
Total debt: $2.5B; 0.90x equity
Free cash flow: $348.6M; 45.0% of revenue

From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.

Latest quarter

Quarter ended Jun 30, 2026

Reported Aug 3

Revenue: $235.9M; +24.7% YoY
EPS: -$0.10; vs $0.27
Free cash flow: $85.8M
Share count: +4.7%; vs a year ago

Insider rating

Last 90 days

No open-market insider buys or sells in the last 90 days.

Weekly insider trend

No trades to chart yet.

Filing buzz

Last 7 days vs normal

0/ 100

This week: 0
Normal week: 1.1
vs normal: 0.0x

SEC filings of any kind. 50 means a normal week.

Institutional ownership

Steady+1.7%

Institutions added 1.7% to their holdings. 222 bought, 193 sold. 5 quarters of net buying in a row.

Shares held by institutions260.9M

Sep '24Jun '26

Safety check

From SEC filings

Share count growthYearly rate, last 3 years

+3.4%

Cash runwayAt last year's cash burn

Cash flow positive

Debt to equityLatest balance sheet: debt compared with what owners have

0.9x · $2.6B debt

Shares outstandingLatest reported

255M

Earnings reports

Last 12

Next reportIn 7 days (est.)Estimated from the same quarter last year

Results filedAug 3
Results filedApr 29
Results filedFeb 12
Results filedNov 5, 2025
Results filedAug 4, 2025

Flags and big holders

Offerings 6 months, flags 12 months, holders 90 days

No offerings, red flags or new big holders. Clean record.

Insider trades

Open-market buys and sells, last 90 days

No open-market buys or sells in 90 days. Grants and option exercises are left out.

"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.

Latest filings

Straight from SEC EDGAR

SoldRichard K MatrosChair, CEO and President, Director

200,000 shares at $20.83 · $4.2M

-11% of holdings
Now owns 1,657,686 shares
Pre-planned sale (10b5-1)
Held by R&A Matros Revocable Trust
Filed 1 day after trade

Sep 8Form 4 ↗

Planned insider saleSep 8 · Form 144 ↗

Stock awardRichard K MatrosChair, CEO and President, Director

13,867 shares

+1% of holdings
Now owns 956,268 shares
Filed 2 days after trade

Aug 31Form 4 ↗

Stock awardMichael Lourenco CostaExecutive VP, CFO & Treasurer

4,158 shares

+1% of holdings
Now owns 469,879 shares
Filed 2 days after trade

Aug 31Form 4 ↗

Stock awardJessica FloresExecutive VP & CAO

382 shares

+1% of holdings
Now owns 72,476 shares
Filed 2 days after trade

Aug 31Form 4 ↗

Stock awardCraig A. BarbaroshDirector

791 shares

+1% of holdings
Now owns 54,580 shares
Filed 2 days after trade

Aug 31Form 4 ↗

Stock awardCatherine CusackDirector

791 shares

+1% of holdings
Now owns 82,847 shares
Filed 2 days after trade

Aug 31Form 4 ↗

Insider tradeSep 2 · Form 4 ↗Insider tradeSep 2 · Form 4 ↗Insider tradeSep 2 · Form 4 ↗Insider tradeSep 2 · Form 4 ↗Insider tradeSep 2 · Form 4 ↗Earnings resultsAug 3 · Form 8-K ↗Quarterly reportAug 3 · Form 10-Q ↗Investor disclosureJul 21 · Form 8-K ↗

Source: SEC EDGAR filings. For informational purposes. Not investment advice.

Report a problem with this page